Skip to main content
. 2023 Jul 10;14:1223312. doi: 10.3389/fendo.2023.1223312

Figure 1.

Figure 1

Experimental Design. (A) The workflow for the benign parathyroid tissue and tissue matched FNA-derived parathyroid organoid metabolic analyses. (B) The workflow for metabolomic analysis of parathyroid organoids and tissues using UHPLC/MS/MS. (C) The workflow for bioenergetic studies of organoids using the Agilent Seahorse Analyzer XF platform. (D) The workflow for the cryopreserved parathyroid organoid hormone production assessment by ELISA.